Evaluation of the safety of C-1311 administered in a phase 1 dose-escalation trial as a 1-hour infusion once every 3 weeks in patients with advanced solid tumors
Year: 2006
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: A. Thomas, A. Anthoney, S. Ahmed, M. Drouin, A. Major, R. L. Capizzi, C. Grieshaber, P. Loadman, C. Twelves
Institutions: University of Bradford, University of Leicester
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2249945607
